IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION
Case Number:
2:16-md-02724
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Sarraf Gentile
- Andrus Anderson
- Dechert LLP
- Edelson Lechtzin
- Shipman & Goodwin
- Krantz & Berman
- McCune Law
- Fiddler Gonzalez
- Berman Tabacco
- Lieff Cabraser
- Barnes & Thornburg
- Ahern & Associates
- Anselmi & Carvelli
- Harkins Cunningham
- Axinn Veltrop
- Cicala Law Firm
- Burns Charest
- Armstrong Teasdale
- Levin Sedran
- Kohn Swift
- Steptoe LLP
- Motley Rice
- Tostrud Law Group
- Gross & Belsky
- Dilworth Paxson
- Freedman Boyd
- Obermayer Rebmann
- Girard Sharp
- Steyer Lowenthal
- Foley & Lardner
- Cera LLP
- Saiber LLC
- Crowell & Moring
- Stradley Ronon
- Faegre Drinker
- Lockridge Grindal
- Rosenn Jenkins
- Barrack Rodos
- Schneider Wallace
- Hach Rose Schirripa
- Cuneo Gilbert
- Kirkland & Ellis
- Welsh & Recker
- DeCotiis FitzPatrick
- Pendley Baudin
- Shapiro Arato
- Lite DePalma
- Hogan Lovells
- Bailey & Glasser
- Joseph Saveri Law Firm
- Competition Law Partners
- Zwerling Schachter
- McConnell Valdes
- Safirstein Law
- Stueve Siegel
- Dugan Law Firm
- Neufeld Scheck
- Spector Roseman
- Wexler Boley
- Goldman Scarlato
- Heins Mills
- Berry Law LLC
- Seeger Weiss
- Zelle LLP
- Hunt Ortmann
- King & Spalding
- Hughes Hubbard
- Ricci Tyrrell
- Schertler Onorato
- Fenwick & West
- Wiggin & Dana
- Faruqi & Faruqi
- Shinder Cantor
- Reed Smith
- Debevoise & Plimpton
- Roberts Law Firm US
- Kasowitz Benson
- Walsh Pizzi
- Boni Zack
- Lyden Chappell
- Simpson Thacher & Bartlett LLP
- Segal McCambridge
- Calcaterra Pollack
- Patterson Belknap
- Hagens Berman
- Bonsignore Trial Lawyers
- Buchanan Ingersoll
- Napoli Shkolnik
- Carella Byrne
- McCracken Stemerman
- Wisner Baum
- Manatt Phelps
- George Feldman
- Bailey Duquette
- Winston & Strawn
- Francis Mailman
- Boies Schiller
- O'Melveny & Myers
- Baker & Hostetler
- Neal & Harwell
- Nussbaum Law Group
- White and Williams
- Kaplan Fox
- Cleary Gottlieb
- Marks O'Neill
- Tycko & Zavareei
- Zuckerman Spaeder
- Barrett Law Group
- Troutman
- Duane Morris
- Williams & Connolly
- Cozen O'Connor
- Scott&Scott
- Miller & Chevalier
- Law Offices of Francis O. Scarpulla
- Petrillo Klein
- Larson King
- Hausfeld LLP
- Kralowec Law
- Furth Salem
- Greenberg Traurig
- Haynes Boone
- Langer Grogan
- Lewis Brisbois
- Weil Gotshal
- Hangley Aronchick
- Gibson Dunn
- Pullman & Comley
- Grabar Law
- Stevens & Lee
- Sills Cummis
- NastLaw
- Berger Montague
- Skadden Arps
- Rule Garza
- Garwin Gerstein
- DiCello Levitt
- Radice Law Firm
- Yarborough Law Firm
- Bartlit Beck
- Kelley Drye
- Proskauer Rose
- Morgan Lewis
- Wolf Haldenstein
- Arnold & Porter
- Tarter Krinsky
- Cotchett Pitre
- Taus Cebulash
- Spiro Harrison
- Paul Weiss
- Lowey Dannenberg
- Steven Williams Law
- DLA Piper
- Freshfields
- Norton Rose
- Bingham McCutchen
- Lowenstein Sandler
- Ballard Spahr
- Cole Schotz
- Gustafson Gluek
- Baker Botts
- Goodwin Procter
- Clark Hill
- Wilson Sonsini
- Seward & Kissel
- Whatley Kallas
- Miller Shah
- Cohen Milstein
- Morrison Foerster
- Robbins Geller
- O’Neill & Borges
- Sperling Kenny
- Earp Cohn
- McDermott Will & Emery
- Zimmerman Reed
- Glancy Prongay
- Harris St. Laurent
- Constantine Cannon
- K&L Gates
- Fox Rothschild
- Polsinelli PC
- Venable LLP
- Blank Rome
- WilmerHale
- Linklaters LLP
- Fine Kaplan
- Grant & Eisenhofer
- Labaton Keller
- Saveri & Saveri
- Curtis Mallet-Prevost
- Latham & Watkins
- White & Case
Companies
- Sun Pharmaceutical Industries Ltd.
- Perrigo Co. PLC
- Sandoz International GmbH
- Impax Laboratories, Inc.
- MSP Recovery
- Walgreens Boots Alliance Inc.
- Novartis AG
- Endo International PLC
- Aurobindo Pharma Ltd.
- The Harvard Drug Group LLC
- Lupin Ltd.
- Amneal Pharmaceuticals Inc.
- Lannett Company, Inc
- Health Care Service Corp.
- Taro Pharmaceutical Industries Ltd.
- Bi-Lo
- The Cigna Group
- Viatris Inc.
- Humana Inc.
- Hi-Tech Pharmacal Co., Inc.
- Molina Healthcare Inc.
- Allergan PLC
- Par Pharmaceutical Cos. Inc.
- Dr. Reddy's Laboratories Ltd.
- Fougera Pharmaceuticals Inc.
- United Food & Commercial Workers International Union
- Bausch Health Cos. Inc.
- Alvogen Group Inc.
- West-Ward Pharmaceutical Corp.
- Cadila Pharmaceuticals Ltd.
- Ascend Laboratories LLC
- Emcure Pharmaceuticals Ltd.
- Akorn Inc.
- Cardinal Health Inc.
- Avet Pharmaceuticals Inc.
- Camber Pharmaceuticals Inc.
- McKesson Corp.
- Glenmark Pharmaceuticals Ltd.
- Red Oak Sourcing LLC
- Zydus Pharmaceuticals Inc.
- International Union Of Operating Engineers
- Cencora Inc.
- G&W Laboratories Inc.
- Upsher-Smith Laboratories Inc.
- Rite Aid Corp.
- Winn-Dixie Stores, Inc.
- Wockhardt Ltd.
- Wockhardt USA LLC
- Pfizer Inc.
- Jubilant Cadista
- American Federation of State County & Municipal Employees
- Teva Pharmaceutical Industries Ltd.
Government Agencies
Sectors & Industries:
-
April 12, 2019
Judge Won't Certify Perrigo's Appeal In Drug Price-Fixing MDL
A Pennsylvania federal judge on Thursday refused to certify an interlocutory appeal from pharmaceutical company Perrigo on claims related to one drug in sprawling price-fixing multidistrict litigation, noting that even if the company's appeal goes through, it must still face claims related to other medications.
-
February 19, 2019
Generics Cos. To Face Most State Claims In Price-Fixing MDL
A Pennsylvania federal judge has largely refused to cull state law claims accusing numerous generic-drug makers of conspiring to fix prices, with only a handful of claims nixed from the massive multidistrict litigation on technical grounds.
-
February 01, 2019
AGs Want To Unlock Redacted Generic Price-Fixing Complaint
A group of state attorneys general and others accusing generic-drug makers of conspiring to fix prices for their products told a Pennsylvania federal judge on Friday that the public importance of the litigation warranted their previously redacted complaint being unsealed in full.
-
January 04, 2019
Judge Won't Gag AGs In Generics Price-Fixing Case
A Pennsylvania federal judge on Friday denied a bid by generic-drug makers to win a court order that would limit what the state attorneys general accusing the companies of price fixing can say publicly about their investigation and the multidistrict litigation over the alleged conduct.
-
January 03, 2019
AGs Blast Generic Cos.' Bid To Gag Price-Fixing Comments
Defending their right to comment publicly on multidistrict litigation and ongoing probes into alleged price-fixing by generic-drug companies, dozens of state attorneys general have told a Pennsylvania federal judge that a speech limitation sought by the drug companies would be unnecessary and unconstitutional.
-
January 01, 2019
Life Sciences Cases To Watch In 2019
The life sciences industry will be keeping an eye on courtrooms around the country in 2019, watching to see how the U.S. Supreme Court decides a legal battle over patent protection for drugs and monitoring the fallout from federal prosecutors' decision to spike a False Claims Act case. Here are seven cases life sciences attorneys say they'll be following in the coming year.
-
December 19, 2018
Generic-Drug Cos. Want AGs To Shut Up About Price-Fixing
Generic-drug companies facing multidistrict litigation and ongoing probes into alleged price-fixing are tired of hearing about them in the news, according to a brief filed in Pennsylvania federal court Tuesday that argues state attorneys general offices have violated legal and ethical requirements to keep mum.
-
November 15, 2018
Judge Won't Quash AGs' Subpoenas In Generic Pricing MDL
The New York and Connecticut attorneys general can keep sending subpoenas to drugmakers as part of their broader investigations into generic-drug price-fixing, a Pennsylvania federal judge has ruled, despite the drug companies’ concern the investigations were circumventing the discovery process for a sprawling multidistrict litigation.
-
November 05, 2018
Humana Seeks Case's Inclusion In Generic Price-Fixing MDL
Humana on Friday asked the Pennsylvania federal court overseeing the sprawling multidistrict litigation over generic drug prices to formally incorporate its action into the MDL, saying its claims target many of the same drugs that the group of states and proposed classes of drug buyers are targeting.
-
October 17, 2018
20 Drugmakers Must Face Generic Price-Fixing MDL
A Pennsylvania federal court has greenlighted the first round of multidistrict litigation accusing more than 20 generic-drug makers of conspiring to fix their prices, excusing only Teligent Inc. from the antitrust litigation.